These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1016367)

  • 1. [Use of steroid and nonsteroid anabolites in ischemic heart disease].
    Leshchinskiĭ LA; Shinkareva IA
    Klin Med (Mosk); 1976 Apr; 54(4):38-43. PubMed ID: 1016367
    [No Abstract]   [Full Text] [Related]  

  • 2. [Economic effectiveness of antirecurrence treatment of peptic ulcer].
    Lomazova MM; Kabkalo DN
    Vrach Delo; 1976 Sep; (9):91-2. PubMed ID: 824821
    [No Abstract]   [Full Text] [Related]  

  • 3. [Change in the protein and electrolyte metabolism under the effect of anabolic steroids and panangin in patients with myocardial infarct].
    Leshchinskiĭ LA; Trusov VV; Shinkareva IA
    Klin Med (Mosk); 1978 Jan; 56(1):69-74. PubMed ID: 633803
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of potassium and magnesium aspartate on experimental myocardial ischemia and infarction].
    Jiang XR; Chen WP; Shi HL; Zhou LF
    Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):36-9. PubMed ID: 6232818
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of butadione on lipid metabolism in chronic ischemic heart disease patients].
    Ermalinskiĭ AF; Balakin AK; Iukhnovets RA; Vedenina RF
    Vrach Delo; 1986 Feb; (2):53-5. PubMed ID: 3085352
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of beta-adrenergic blocking agents and anabolic steroids in ischemic heart disease].
    Girina NI
    Vrach Delo; 1979 Dec; (12):48-50. PubMed ID: 43030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta-adrenergic blocking agents ATP and anabolic hormones in the treatment of ischemic heart disease].
    Smolenskiĭ VS; Abinder AA
    Sov Med; 1977 Jan; (1):44-8. PubMed ID: 15321
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of metabolically active agents in ischemic heart disease patients].
    Denisiuk VI
    Vrach Delo; 1986 Aug; (8):11-4. PubMed ID: 3776144
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of Nerobol in the treatment of patients with rheumatic heart disease and circulatory insufficiency].
    Beĭ PI
    Klin Med (Mosk); 1968 Jun; 46(6):104-6. PubMed ID: 5710561
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of an anabolic steroid on phenylalaninemia in dystrophic infants].
    Panigada G; Perletti L; Magni L; Giovannini M
    Minerva Pediatr; 1968 Mar; 20(9):491-4. PubMed ID: 5745083
    [No Abstract]   [Full Text] [Related]  

  • 11. [Certain methods of drug therapy of ischemic heart disease].
    Leshchinskiĭ LA; Shinkareva IA
    Sov Med; 1975 Apr; (4):68-74. PubMed ID: 1188463
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of progressive muscular dystrophy with anabolics and uridine-5-triphosphoric acid].
    Valente VL; Caprarulo CC; Luchetta MR; Nenkies L; Miani J; De Zubizarreta CS
    Prensa Med Argent; 1966 May; 53(20):1130-4. PubMed ID: 5916532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of anabolic hormones for the treatment of cardiovascular patients].
    Zharov EI; Segal' RG
    Kardiologiia; 1969 Jan; 9(1):144-53. PubMed ID: 4896687
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preventive treatment of ischemic heart disease with obsidan and nerobolil under ambulatory conditions].
    Ianovskiĭ GV; Shevchuk SG; Girina NI; Petrusha GN
    Vrach Delo; 1978 Jun; (6):16-8. PubMed ID: 695461
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined therapeutic use of nerobol and potassium salts in ischemic heart disease].
    Leschinskiĭ LA; Kharitonova VV
    Ter Arkh; 1972 Sep; 44(9):40-4. PubMed ID: 4660401
    [No Abstract]   [Full Text] [Related]  

  • 16. [Calcium and magnesium metabolism in patients with active rheumatism during treatment with anabolic steroids].
    Kuz'min IuP
    Ter Arkh; 1976; 48(5):87-90. PubMed ID: 948804
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities of differential treatment of the chronic form of ischemic heart disease].
    Miasnikov LA; Metelitsa VI
    Ter Arkh; 1973; 45(6):8-21. PubMed ID: 4148246
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
    Denisiuk VI; Shkliar MB
    Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of anabolic steroids and adrenergic beta receptor blockaders on the indicators of rheogram of the aorta and lungs in patients with ischemic heart disease].
    Sharlaĭ IR
    Vrach Delo; 1974 Aug; 0(8):15-7. PubMed ID: 4153197
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of nerobol in combination with potassium salts in patients with chronic coronary insufficiency].
    Leshchinskiĭ LA; Kharitonova VV
    Klin Med (Mosk); 1970 Oct; 48(10):38-42. PubMed ID: 5505243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.